- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Internal Medicine
Cardiology Month in Review: November 2021
November 27, 2021
November's cardiology month in review features stories from the AHA's late-breaking sessions and Kidney Week 2021.
ESC Releases New Guidance on Cardiovascular Disease Management During COVID-19 Pandemic
November 24, 2021
Dr. Gregory Weiss offers a breakdown of the recent ESC guidelines for management of cardiovascular disease during the ongoing COVID-19 pandemic, including specific insight into care pathways, treatment, and follow-up.
Bariatric Surgery Could Cut Risk of Adverse Liver, Cardiovascular Outcomes in NASH
November 22, 2021
An analysis of data from the SPLENDOR study suggests 88% reduction in risk of progression of fatty liver to cirrhosis, liver cancer, or liver-related death and a 70% reduction in risk of major adverse cardiovascular events in patients with NASH and obesity.
Digital Monitoring Programs Can Aid in Reaching Blood Pressure, Cholesterol Goals
November 19, 2021
The latest data from the digital care transformation program provides insight into effects of digital monitoring programs on helping patients achieve blood pressure and cholesterol goals.
AHA 2021: Top Data Slideshow
November 17, 2021
Every year, AHA Scientific Sessions provides clinicians and researchers with a glimpse into the latest data from clinical trials. Our editorial staff's top picks for late-breaking data from AHA 2021 Scientific Sessions includes AVATAR, RAPID CABG, REVERSE-IT, and more.
Low-Dose Aspirin Not Linked to Increased Dementia Risk in Patients with Diabetes
November 16, 2021
The ASCEND trial indicates low-dose aspirin use was associated with a nonsignificant reduction in risk of dementia among patients with diabetes and no history of cardiovascular disease.
AHA Study Assesses Risk of Pericarditis and Myocarditis Associated with COVID-19 Vaccines
November 15, 2021
A study from the Intermountain Heart Institute details the risk of pericarditis and myocarditis associated with COVID-19 vaccines among patients from within their institution's health system.
Deepak Bhatt, MD, MPH: Sotagliflozin Provides Consistent Benefit Across Spectrum of Kidney Function
November 14, 2021
Deepak Bhatt, MD, MPH, discusses the results of a pooled analysis of the SOLOIST and SCORED trials assessing effects of sotagliflozin based on baseline eGFR among patients included in the trials.
The PA Experience at ACLM 2021: Lettuce Discuss Benefits of Lifestyle Medicine
November 11, 2021
Laura Ross, PA-C, details her experiences at the American College of Lifestyle Medicine conference and the role of lifestyle modification as a cornerstone of cardiovascular risk management.
Dapagliflozin Use Provides Renal Benefit in CKD, Regardless of Diabetes Status
November 11, 2021
Data presented at ASN Kidney Week 2021 suggests dapagliflozin use was associated with a reduction in the rate of kidney function decline in patients with chronic kidney disease, regardless of whether they have diabetes.